Institutional Ownership
Dermata Therapeutics Inc
CUSIP 249845504COMDRMAQ1 2026
13D / 13G Filings
5
Schedule 13D/13G on record
Beneficial Filers
2
Distinct reporting persons
Largest Stake
24.7%
Max % of class reported
Institutional Holders
7
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
5 filings · latest Feb 23, 2026
Top Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Geode Capital Management, LLC | 48.3K | $58.5K |
| 2 | Ubs Group AG | 35.6K | $43.1K |
| 3 | Welch & Forbes LLC | 20.0K | $24.2K |
| 4 | Mcf Advisors LLC | 1.7K | $2.1K |
| 5 | Tower Research Capital LLC (Trc) | 716 | $866 |
| 6 | Sbi Securities Co., Ltd. | 101 | $122 |
| 7 | Citigroup Inc | 1 | $1 |